Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.
Chen R, Zinzani PL, Fanale MA, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Zhang Y, Ricart AD, Balakumaran A, Moskowitz CH; KEYNOTE-087. Chen R, et al. Among authors: vassilakopoulos tp. J Clin Oncol. 2017 Jul 1;35(19):2125-2132. doi: 10.1200/JCO.2016.72.1316. Epub 2017 Apr 25. J Clin Oncol. 2017. PMID: 28441111 Free PMC article. Clinical Trial.
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Rassidakis GZ, Medeiros LJ, Viviani S, Bonfante V, Nadali GP, Vassilakopoulos TP, Mesina O, Herling M, Angelopoulou MK, Giardini R, Chilosi M, Kittas C, McLaughlin P, Rodriguez MA, Romaguera J, Bonadonna G, Gianni AM, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH. Rassidakis GZ, et al. Among authors: vassilakopoulos tp. J Clin Oncol. 2002 Mar 1;20(5):1278-87. doi: 10.1200/JCO.2002.20.5.1278. J Clin Oncol. 2002. PMID: 11870170
Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites.
Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN, Barbounis A, Grigorakis V, Karkantaris C, Anargyrou K, Chatziioannou M, Rombos J, Boussiotis VA, Vaiopoulos G, Kittas C, Pangalis GA. Vassilakopoulos TP, et al. Eur J Haematol. 2001 Nov-Dec;67(5-6):279-88. doi: 10.1034/j.1600-0609.2001.00561.x. Eur J Haematol. 2001. PMID: 11872075
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN, Kokoris SI, Kyrtsonis MC, Tsaftaridis P, Karkantaris C, Anargyrou K, Boutsis DE, Variamis E, Michalopoulos T, Boussiotis VA, Panayiotidis P, Papavassiliou C, Pangalis GA. Vassilakopoulos TP, et al. Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):765-81. doi: 10.1016/j.ijrobp.2003.11.029. Int J Radiat Oncol Biol Phys. 2004. PMID: 15183480
Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
Kalpadakis C, Pangalis GA, Dimopoulou MN, Vassilakopoulos TP, Kyrtsonis MC, Korkolopoulou P, Kontopidou FN, Siakantaris MP, Dimitriadou EM, Kokoris SI, Tsaftaridis P, Plata E, Angelopoulou MK. Kalpadakis C, et al. Among authors: vassilakopoulos tp. Hematol Oncol. 2007 Sep;25(3):127-31. doi: 10.1002/hon.820. Hematol Oncol. 2007. PMID: 17514771
Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphoma.
Doussis-Anagnostopoulou IA, Vassilakopoulos TP, Thymara I, Korkolopoulou P, Angelopoulou MK, Siakantaris MP, Kokoris SI, Dimitriadou EM, Kalpadakis C, Matzouranis M, Kaklamanis L, Panayiotidis P, Kyrtsonis MC, Androulaki A, Patsouris E, Kittas C, Pangalis GA. Doussis-Anagnostopoulou IA, et al. Among authors: vassilakopoulos tp. Clin Cancer Res. 2008 Mar 15;14(6):1759-66. doi: 10.1158/1078-0432.CCR-07-1395. Clin Cancer Res. 2008. PMID: 18347177
Hodgkin lymphoma: Introduction.
Engert A, Vassilakopoulos TP. Engert A, et al. Among authors: vassilakopoulos tp. Semin Hematol. 2016 Jul;53(3):137-8. doi: 10.1053/j.seminhematol.2016.05.001. Epub 2016 May 12. Semin Hematol. 2016. PMID: 27496303 No abstract available.
Prognostic factors in Hodgkin lymphoma.
Bröckelmann PJ, Angelopoulou MK, Vassilakopoulos TP. Bröckelmann PJ, et al. Among authors: vassilakopoulos tp. Semin Hematol. 2016 Jul;53(3):155-64. doi: 10.1053/j.seminhematol.2016.05.003. Epub 2016 May 12. Semin Hematol. 2016. PMID: 27496306 Review.
256 results